Cargando…
The Protein-Binding Behavior of Platinum Anticancer Drugs in Blood Revealed by Mass Spectrometry
Cisplatin and its analogues are widely used as chemotherapeutic agents in clinical practice. After being intravenously administrated, a substantial amount of platinum will bind with proteins in the blood. This binding is vital for the transport, distribution, and metabolism of drugs; however, toxici...
Autores principales: | Wang, Jingchen, Tao, Jianmei, Jia, Shuailong, Wang, Meiqin, Jiang, Hongliang, Du, Zhifeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7911130/ https://www.ncbi.nlm.nih.gov/pubmed/33572935 http://dx.doi.org/10.3390/ph14020104 |
Ejemplares similares
-
Elucidation of the Mechanism of Action for Metal Based Anticancer Drugs by Mass Spectrometry-Based Quantitative Proteomics
por: Jia, Shuailong, et al.
Publicado: (2019) -
Monofunctional Platinum(II) Anticancer Agents
por: Jin, Suxing, et al.
Publicado: (2021) -
Anticancer Platinum Drugs Update
por: Ciarimboli, Giuliano
Publicado: (2021) -
Identification of sitagliptin binding proteins by affinity purification mass spectrometry: Sitagliptin binding proteins identified by affinity purification mass spectrometry
por: Wang, Xue-Ning, et al.
Publicado: (2022) -
Interaction of Natural Compounds in Licorice and Turmeric with HIV-NCp7 Zinc Finger Domain: Potential Relevance to the Mechanism of Antiviral Activity
por: Wang, Runjing, et al.
Publicado: (2021)